Announcement
Collapse
No announcement yet.
Treatments
Collapse
There are no conversations in this channel.
Please log in to your account to view your subscribed posts.
Topics | Statistics | Last Post | ||
---|---|---|---|---|
BMC Infect Dis . Efficacy of antiviral therapies for COVID-19: a systematic review of randomized controlled trials
by tetano
Started by tetano, February 2, 2022, 04:55 AM
|
0 responses
37 views
0 likes
|
Last Post
by tetano
February 2, 2022, 04:55 AM
|
||
Therapie . Does the public know when a scientific controversy is over? Public perceptions of hydroxychloroquine in France between April 2020 and June 2021
by tetano
Started by tetano, February 2, 2022, 04:53 AM
|
0 responses
29 views
0 likes
|
Last Post
by tetano
February 2, 2022, 04:53 AM
|
||
J Biol Chem . Tafenoquine and its derivatives as inhibitors for the Severe Acute Respiratory Syndrome Coronavirus 2
by tetano
Started by tetano, February 2, 2022, 04:51 AM
|
0 responses
30 views
0 likes
|
Last Post
by tetano
February 2, 2022, 04:51 AM
|
||
Started by tetano, February 2, 2022, 04:48 AM
|
0 responses
32 views
0 likes
|
Last Post
by tetano
February 2, 2022, 04:48 AM
|
||
Reprod Toxicol . Reproductive and developmental safety of nirmatrelvir (PF-07321332), an oral SARS-CoV-2 M pro inhibitor in animal models
by tetano
Started by tetano, February 2, 2022, 04:47 AM
|
0 responses
32 views
0 likes
|
Last Post
by tetano
February 2, 2022, 04:47 AM
|
||
Started by tetano, February 2, 2022, 04:37 AM
|
0 responses
33 views
0 likes
|
Last Post
by tetano
February 2, 2022, 04:37 AM
|
||
Started by tetano, February 2, 2022, 04:24 AM
|
0 responses
36 views
0 likes
|
Last Post
by tetano
February 2, 2022, 04:24 AM
|
||
Started by tetano, February 2, 2022, 04:17 AM
|
0 responses
21 views
0 likes
|
Last Post
by tetano
February 2, 2022, 04:17 AM
|
||
Intern Emerg Med . SIMEU position paper on non-invasive respiratory support in COVID-19 pneumonia
by tetano
Started by tetano, February 2, 2022, 04:02 AM
|
0 responses
8 views
0 likes
|
Last Post
by tetano
February 2, 2022, 04:02 AM
|
||
Front Med (Lausanne) . Delayed Infliximab Treatment Affects the Outcomes of Patients With Crohn's Disease During the COVID-19 Epidemic in China: A Propensity Score-Matched Analysis
by tetano
Started by tetano, February 1, 2022, 04:49 AM
|
0 responses
27 views
0 likes
|
Last Post
by tetano
February 1, 2022, 04:49 AM
|
No topics found.
-
Page of 0
-
Filter